Profit Or Loss [Abstract]

Xbrane Biopharma - Filing #689990

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
57 618 SEK
10 709 SEK
Other income
20 914 SEK
4 848 SEK
Profit (loss) from operating activities
166 217 SEK
180 583 SEK
Finance costs
2 296 SEK
2 643 SEK
Profit (loss) before tax
168 513 SEK
183 226 SEK
Tax expense (income)
SEK
SEK
Profit (loss) from continuing operations
168 513 SEK
183 226 SEK
Profit (loss) from discontinued operations
4 001 SEK
5 150 SEK
Profit (loss)
172 513 SEK
172 513 SEK
188 376 SEK
188 376 SEK
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
172 513 SEK
188 376 SEK
Profit (loss), attributable to non-controlling interests
SEK
SEK
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share from continuing operations
659.00
777.00
Basic earnings (loss) per share
675.00
798.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share from continuing operations
659.00
777.00
Diluted earnings (loss) per share
675.00
798.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.